Jul 27, 2026 4:05pm EDT OPKO Health Reports Second Quarter 2026 Business Highlights and Financial Results
Jul 23, 2026 12:30pm EDT OPKO Health to Report Second Quarter 2026 Financial Results on July 27, 2026
Jun 15, 2026 8:00am EDT Preclinical Data for OPKO Biologics' OPK8801001 in Acromegaly Presented at ENDO 2026
May 12, 2026 8:00am EDT OPKO Health’s ModeX Therapeutics Will Present Data Demonstrating In Vivo CAR-T Cell Generation and Deep B-Cell Depletion in Preclinical Studies
Apr 30, 2026 8:30am EDT OPKO Health Expands Nicoya Agreement to Support RAYALDEE® Commercialization in Greater China
Apr 30, 2026 8:00am EDT BioReference® Launches BioReference Direct™, Expanding Access to Consumer-Initiated Diagnostic Testing Through a Fully Integrated Digital Platform
Apr 28, 2026 4:05pm EDT OPKO Health Reports First Quarter 2026 Business Highlights and Financial Results
Apr 22, 2026 8:00am EDT OPKO Health’s ModeX Therapeutics Begins Clinical Trial of Tetraspecific Antibody for Treatment of B-cell Lymphomas
Apr 08, 2026 8:00am EDT OPKO Health’s ModeX Therapeutics Initiates Clinical Trial of MDX2301 for the Prevention of COVID-19